Ropivacaine罗哌卡因,84057-95-4

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Ropivacaine

CAS No. : 84057-95-4

MCE 国际站：Ropivacaine

产品活性：Ropivacaine 是一种有效的钠通道 (sodium channel) 阻断剂。Ropivacaine 通过可逆地抑制钠离子内流 (sodium ion influx) 从而引起神经纤维脉冲传导阻滞。Ropivacaine 也是一种 K_2P (双孔钾通道) TREK-1 的抑制剂，在 COS-7 细胞膜上的 IC₅₀ 值为 402.7 μM。Ropivacaine 用于神经性疼痛的缓解的相关研究。

研究领域：Membrane Transporter/Ion Channel

作用靶点：Sodium Channel  |  Potassium Channel

In Vivo: Epidural administration of Ropivacaine effectively blocks neuropathic pain (both mechanical allodynia and heat hyperalgesia) without induction of analgesic tolerance and significantly delays the development of neuropathic pain produced by peripheral nerve injury.
?Ropivacaine inhibits pressure-induced increases in filtration coefficient (Kf) without affecting pulmonary artery pressure (Ppa), pulmonary capillary pressures (Ppc), and zonal characteristics (ZC).
?Ropivacaine prevents pressure-induced lung edema and associated hyperpermeability as evidence by maintaining PaO2, lung wet-to-dry ratio and plasma volume in levels similar to sham rats.
?Ropivacaine inhibits pressure-induced NO production as evidenced by decreased lung nitro-tyrosine content when compared to hypertensive lungs.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Membrane Transporter/Ion Channel Compound Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Drug Repurposing Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  NMPA-Approved Drug Library  |  FDA Approved & Pharmacopeial Drug Library  |  Anti-Alzheimer's Disease Compound Library  |  Neuroprotective Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Neurodegenerative Disease-related Compound Library  |  Mechanoreceptors Compound Library  |  Targeted Diversity Library  |  Rare Diseases Drug Library  |  Children’s Drug Library  |  Sodium Channel Blocker Library  |  Potassium Channel Compound Library  |  FDA-Approved Anticancer Drug Library  |  Human Metabolite Library  |  Anti-Prostate Cancer Compound Library  |  Heterocyclic Compound Library  |  Off-patent Drug Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Mitochondrial Toxicity Compound Library  |  Ion Channel Compound Library  |  Nigericin sodium salt  |  Yoda 1  |  BAPTA-AM  |  Minocycline hydrochloride  |  Branaplam  |  Amiloride hydrochloride  |  Rosuvastatin Calcium  |  SCH-23390 hydrochloride  |  Halofuginone  |  Glibenclamide  |  Quinidine (15% dihydroquinidine)  |  Tetrandrine  |  Carbamazepine  |  Riluzole  |  20(S)-Ginsenoside Rg3  |  DCPIB  |  E-4031  |  Amiodarone hydrochloride  |  TPC2-A1-P  |  Minoxidil  |  TRAM-34  |  Tannic acid  |  Lidocaine  |  (±)-Naringenin  |  Quinine  |  Terfenadine  |  SKF-96365 hydrochloride  |  Amitriptyline hydrochloride  |  Mefloquine hydrochloride  |  Veratridine

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds